P. Marcellin Et Al. , "Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no Detectable Resistance: 8 Year Results from Two Phase 3 Trials," 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , vol.60, Massachusetts, United States Of America, 2014
Marcellin, P. Et Al. 2014. Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no Detectable Resistance: 8 Year Results from Two Phase 3 Trials. 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , (Massachusetts, United States Of America).
Marcellin, P., Gane, E. J., Flisiak, R., Trinh, H. N., Petersen, J., GÜREL, S., ... Kaita, K. D.(2014). Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no Detectable Resistance: 8 Year Results from Two Phase 3 Trials . 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America
Marcellin, Patrick Et Al. "Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no Detectable Resistance: 8 Year Results from Two Phase 3 Trials," 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 2014
Marcellin, Patrick Et Al. "Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no Detectable Resistance: 8 Year Results from Two Phase 3 Trials." 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , Massachusetts, United States Of America, 2014
Marcellin, P. Et Al. (2014) . "Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no Detectable Resistance: 8 Year Results from Two Phase 3 Trials." 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases , Massachusetts, United States Of America.
@conferencepaper{conferencepaper, author={Patrick Marcellin Et Al. }, title={Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no Detectable Resistance: 8 Year Results from Two Phase 3 Trials}, congress name={65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases}, city={Massachusetts}, country={United States Of America}, year={2014}}